The DNA mutation that causes Duchenne muscular dystrophy in mice can be corrected, with minimal off-target effects, by gold nanoparticles carrying the CRISPR components.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Innovative approaches to combat antibiotic resistance: integrating CRISPR/Cas9 and nanoparticles against biofilm-driven infections
BMC Medicine Open Access 20 August 2025
-
CRISPR/Cas9-mediated knock-in of BRCA1/2 mutations restores response to olaparib in pancreatic cancer cell lines
Scientific Reports Open Access 31 October 2023
-
Nanoparticles-mediated CRISPR-Cas9 gene therapy in inherited retinal diseases: applications, challenges, and emerging opportunities
Journal of Nanobiotechnology Open Access 03 December 2022
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Hsu, P. D., Lander, E. S. & Zhang, F. Cell 157, 1262–1278 (2014).
Doudna, J. A. & Charpentier, E. Science 346, 1258096 (2014).
Tabebordbar, M. et al. Science 351, 407–411 (2016).
Nelson, C. E. et al. Science 351, 403–407 (2016).
Long, C. et al. Science 351, 400–403 (2016).
Lee, K. et al. Nat. Biomed. Eng. https://doi.org/10.1038/s41551-017-0137-2 (2017).
Ramadasan-Nair, R. et al. J. Biol. Chem. 289, 485–509 (2014).
Wang, M., Glass, Z. A. & Xu, Q. Gene Ther. 24, 144–150 (2017).
Wang, H.-X. et al. Chem. Rev. 117, 9874–9906 (2017).
Yin, H., Kauffman, K. J. & Anderson, D. G. Nat. Rev. Drug Discov. 16, 387–399 (2017).
Staahl, B. T. et al. Nat. Biotechnol. 35, 431–434 (2017).
Zuris, J. A. et al. Nat. Biotechnol. 33, 73–80 (2015).
Wang, M. et al. Proc. Natl Acad. Sci. USA 113, 2868–2873 (2016).
Ran, F. A. et al. Nat. Protoc 8, 2281–2308 (2013).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Glass, Z., Li, Y. & Xu, Q. Nanoparticles for CRISPR–Cas9 delivery. Nat Biomed Eng 1, 854–855 (2017). https://doi.org/10.1038/s41551-017-0158-x
Published:
Issue date:
DOI: https://doi.org/10.1038/s41551-017-0158-x
This article is cited by
-
Innovative approaches to combat antibiotic resistance: integrating CRISPR/Cas9 and nanoparticles against biofilm-driven infections
BMC Medicine (2025)
-
CRISPR/Cas9-mediated knock-in of BRCA1/2 mutations restores response to olaparib in pancreatic cancer cell lines
Scientific Reports (2023)
-
Stimuli-responsive nanoformulations for CRISPR-Cas9 genome editing
Journal of Nanobiotechnology (2022)
-
Nanoparticles-mediated CRISPR-Cas9 gene therapy in inherited retinal diseases: applications, challenges, and emerging opportunities
Journal of Nanobiotechnology (2022)
-
Efficiency of Chitosan-Coated PLGA Nanocarriers for Cellular Delivery of siRNA and CRISPR/Cas9 Complex
Journal of Pharmaceutical Innovation (2022)
